DRUG-TREATMENT OF PARKINSONS-DISEASE - IS POLYPHARMACY BEST

被引:11
作者
SWANSON, PD
机构
[1] Division of Neurology, RG-27, University of Washington School of Medicine
关键词
D O I
10.1136/jnnp.57.4.401
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:401 / 403
页数:3
相关论文
共 29 条
[22]  
SCHMIDT D, 1983, EPILEPSIA, V24, P368, DOI 10.1111/j.1528-1157.1983.tb04900.x
[23]   THE ANTIPARKINSON EFFICACY OF DEPRENYL DERIVES FROM TRANSIENT IMPROVEMENT THAT IS LIKELY TO BE SYMPTOMATIC [J].
SCHULZER, M ;
MAK, E ;
CALNE, DB .
ANNALS OF NEUROLOGY, 1992, 32 (06) :795-798
[24]   THE EFFECT OF DEPRENYL (SELEGILINE) ON THE NATURAL-HISTORY OF PARKINSONS-DISEASE [J].
TETRUD, JW ;
LANGSTON, JW .
SCIENCE, 1989, 245 (4917) :519-522
[25]   EARLY COMBINATION THERAPY (BROMOCRIPTINE AND LEVODOPA) DOES NOT PREVENT MOTOR FLUCTUATIONS IN PARKINSONS-DISEASE [J].
WEINER, WJ ;
FACTOR, SA ;
SANCHEZRAMOS, JR ;
SINGER, C ;
SHELDON, C ;
CORNELIUS, L ;
INGENITO, A .
NEUROLOGY, 1993, 43 (01) :21-27
[26]   AUTOPSY FINDINGS IN PARKINSONISM FOLLOWING TREATMENT WITH LEVODOPA [J].
YAHR, MD ;
WOLF, A ;
ANTUNES, JL ;
MIYOSHI, K ;
DUFFY, P .
NEUROLOGY, 1972, 22 (05) :56-&
[27]  
1993, BRIT MED J, V207, P469
[28]  
1989, NEW ENGL J MED, V321, P1364
[29]  
1993, NEW ENGL J MED, V328, P176